All In Biotech

Free tool

FAERS Monitor: Zoladex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020578 or its brand name (Zoladex, Goserelin Acetate). Reports on generic versions are filed under their own applications.

Reports

13,568

Serious

12,237

90% of reports

Hospitalization

3,988

Death reported

2,422

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death1,594
  • malignant neoplasm progression1,367
  • fatigue925
  • metastases to bone706
  • neutropenia680
  • nausea624
  • asthenia540
  • hot flush527
  • diarrhoea521
  • off label use493
  • pain492
  • arthralgia457
  • metastases to liver451
  • dyspnoea449
  • headache418

Reports by year received

View as table
YearReports
2004224
2005218
2006246
2007274
2008296
2009298
2010265
2011385
2012485
2013405
2014446
2015589
2016571
2017485
2018691
2019777
2020902
20211,190
20221,030
20231,255
20241,020
2025836
2026680

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,040,591 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
metastases to boneSignal70669.664.745,673
metastases to liverSignal45140.837.217,045
malignant neoplasm progressionSignal1,36721.019.925,741
hot flushSignal52710.910.04,717
neutropeniaSignal6807.87.24,021
deathSignal1,5942.92.72,022
astheniaSignal5402.22.1370
fatigue9251.81.7369
arthralgia4571.71.6135
diarrhoea5211.31.227
pain4921.21.124
dyspnoea4491.21.120
nausea6241.21.126
headache4181.00.90
off label use4930.90.89

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.